The demand for factor VIII and for factor IX and the toll fractionation product surplus management

被引:9
作者
Calizzani, Gabriele [1 ]
Profili, Samantha [1 ]
Candura, Fabio [1 ]
Lanzoni, Monica [1 ,2 ]
Vaglio, Stefania [1 ,3 ]
Cannata, Livia [1 ]
Liumbruno, Giancarlo M. [4 ,5 ,6 ]
Franchini, Massimo [7 ]
Mannucci, Pier Mannuccio [2 ]
Grazzini, Giuliano [1 ]
机构
[1] Italian Natl Blood Ctr, Natl Inst Hlth, I-00162 Rome, Italy
[2] IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Sci Direct, Milan, Italy
[3] Univ Roma La Sapienza, Fac Med & Psychol, Rome, Italy
[4] San Giovanni Calibita Fatebenefratelli Hosp, AFAR, Immunohematol Unit, Rome, Italy
[5] San Giovanni Calibita Fatebenefratelli Hosp, AFAR, Med Unit, Rome, Italy
[6] San Giovanni Calibita Fatebenefratelli Hosp, AFAR, Clin Pathol Unit, Rome, Italy
[7] Carlo Poma Hosp, Dept Transfus Med & Haematol, Mantua, Italy
关键词
plasma-derived medicinal products; factor VIII; factor IX; demand; surplus management; HEMOPHILIA-A; MEDICINAL PRODUCTS; PLASMA; PROPHYLAXIS; PREVALENCE; DISEASE; FUTURE; SYSTEM; CARE;
D O I
10.2450/2013.011s
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S64 / S76
页数:13
相关论文
共 42 条
  • [1] [Anonymous], ANN REP 2008 2009
  • [2] [Anonymous], 4 INT STAND FACT 9 H
  • [3] [Anonymous], 2015, WHO model list of essential medicines, 19th list
  • [4] [Anonymous], DAT SUMM IT REG HAEM
  • [5] [Anonymous], EMACHMPBPWP16191999
  • [6] [Anonymous], EMACHMPBPWP16251999
  • [7] [Anonymous], WHO INT STAND 8 INT
  • [8] Modern plasma fractionation
    Burnouf, Thierry
    [J]. TRANSFUSION MEDICINE REVIEWS, 2007, 21 (02) : 101 - 117
  • [9] Calizzani G, 2012, 1253 ISTISAN
  • [10] The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy
    Calizzani, Gabriele
    Vaglio, Stefania
    Candura, Fabio
    Profili, Samantha
    Lanzoni, Monica
    Cristiano, Karen
    Tamburrini, Maria Rita
    Grazzini, Giuliano
    Oleari, Fabrizio
    [J]. BLOOD TRANSFUSION, 2013, 11 : S6 - S12